February 2, 2024 01:53 PM EST
Pharma
Law

Hik­ma to pay $115M in cash, $35M in do­na­tions to set­tle opi­oid claims

Katherine Lewin

News Reporter

Lon­don-based Hik­ma Phar­ma­ceu­ti­cals has reached an agree­ment to set­tle al­le­ga­tions brought against the com­pa­ny by US states and lo­cal gov­ern­ments for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times